[ad_1] Elon Musk and Sam Altman are still taking swipes at each other on Musk’s social media platform X. While both men were founders at OpenAI, where Altman is CEO, they have subsequently sparred across social media, court filings, and corporate blog posts. The latest exchange began when Altman posted what he called “a tale…
[ad_1] At nearly the same moment as Nvidia CEO Jensen Huang was expressing surprise over OpenAI’s multibillion-dollar deal with competitor AMD — shortly after his company agreed to invest up to $100 billion into the AI model maker — Sam Altman was saying that more such deals are in the works. Huang appeared on CNBC’s…
[ad_1] During a Reddit ask-me-anything session on Friday, OpenAI CEO Sam Altman and key members of the GPT-5 team were peppered with questions about the new model and requests to bring back its previous model, GPT-4o. They also asked Altman about the most embarrassing — and perhaps funniest — snafu in the presentation, the “chart…
[ad_1] In brief: As political dynamics shift in Washington, a new alliance is taking shape. Sam Altman, chief executive of OpenAI, has quickly become a key adviser on artificial intelligence policy for President Trump, stepping into the role recently left vacant by Elon Musk. Less than a month after Musk – formerly a fixture in…
Shorouk Express Just two weeks before the meeting with Altman, Kyle told an AI industry conference in California that the U.K. would be “an agile, proactive partner” to tech firms, and invited them to train and deploy their technology in the country. But Kyle admitted “regret” last week over the U.K. government’s messaging around AI…
[ad_1] An excerpt from the upcoming book “The Optimist: Sam Altman, OpenAI, and the Race to Invent the Future” offers new details about why OpenAI’s board briefly fired CEO Sam Altman back in 2023. Written by Wall Street Journal reporter Keach Hagey, the book claims the nonprofit’s board members became increasingly concerned after learning about…
[ad_1] OpenAI CEO Sam Altman is doubling down on Retro Biosciences, a biotech startup based in San Francisco that wants humans to live 10 years longer than what it calls a healthy human lifespan. Altman previously provided Retro Biosciences’ entire seed round of $180 million. Now, the startup is raising a $1 billion Series A…
